Suzhou, China · Founded 2017 · Privately Held (backing)
Developer of precision medicines and smart diagnostic devices designed to transform disease management across hematology, cardiology, neurology and cancer. Atantares is based in Suzhou, China and was founded in 2017. Its last reported valuation was $14.5 million in Jul 2025. It has raised $28 million.
Last reported valuation
$14.5M
Oct 2026
Priced at
—
Total raised
$28.0M
Last round
—
Cap table — not yet on record
Atantares's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Atantares with a free account
·The complete investor list: 17 names
·Watch Atantares: the Monday email on marks, rounds and moves
